Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HCT0
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 4 |
GO:0006487 | protein N-linked glycosylation | 5 | 4 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0019538 | protein metabolic process | 3 | 4 |
GO:0036211 | protein modification process | 4 | 4 |
GO:0043170 | macromolecule metabolic process | 3 | 4 |
GO:0043412 | macromolecule modification | 4 | 4 |
GO:0043413 | macromolecule glycosylation | 3 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0070085 | glycosylation | 2 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 4 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0016462 | pyrophosphatase activity | 5 | 4 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 4 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 4 |
GO:0047874 | dolichyldiphosphatase activity | 6 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 231 | 233 | PF00675 | 0.433 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.433 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.414 |
CLV_PCSK_PC1ET2_1 | 57 | 59 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 231 | 235 | PF00082 | 0.409 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.370 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.708 |
DOC_CKS1_1 | 112 | 117 | PF01111 | 0.407 |
DOC_CYCLIN_yCln2_LP_2 | 188 | 194 | PF00134 | 0.280 |
DOC_MAPK_MEF2A_6 | 184 | 192 | PF00069 | 0.280 |
DOC_PP1_RVXF_1 | 141 | 147 | PF00149 | 0.426 |
DOC_PP1_RVXF_1 | 191 | 198 | PF00149 | 0.226 |
DOC_PP2B_LxvP_1 | 188 | 191 | PF13499 | 0.469 |
DOC_PP4_FxxP_1 | 112 | 115 | PF00568 | 0.356 |
DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.464 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.507 |
DOC_USP7_UBL2_3 | 57 | 61 | PF12436 | 0.597 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.403 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.540 |
LIG_14-3-3_CanoR_1 | 231 | 240 | PF00244 | 0.687 |
LIG_14-3-3_CanoR_1 | 96 | 104 | PF00244 | 0.407 |
LIG_Actin_WH2_2 | 127 | 145 | PF00022 | 0.382 |
LIG_BRCT_BRCA1_1 | 81 | 85 | PF00533 | 0.501 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.218 |
LIG_FHA_1 | 221 | 227 | PF00498 | 0.601 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.319 |
LIG_FHA_1 | 99 | 105 | PF00498 | 0.342 |
LIG_LIR_Apic_2 | 110 | 115 | PF02991 | 0.393 |
LIG_LIR_Apic_2 | 123 | 127 | PF02991 | 0.345 |
LIG_LIR_Gen_1 | 82 | 92 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 15 | 19 | PF02991 | 0.380 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.436 |
LIG_SH2_CRK | 16 | 20 | PF00017 | 0.249 |
LIG_SH2_PTP2 | 124 | 127 | PF00017 | 0.287 |
LIG_SH2_STAP1 | 135 | 139 | PF00017 | 0.430 |
LIG_SH2_STAT3 | 113 | 116 | PF00017 | 0.226 |
LIG_SH2_STAT3 | 28 | 31 | PF00017 | 0.579 |
LIG_SH2_STAT3 | 92 | 95 | PF00017 | 0.501 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.239 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.501 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.577 |
LIG_SH3_1 | 70 | 76 | PF00018 | 0.556 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.356 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.569 |
LIG_SH3_3 | 70 | 76 | PF00018 | 0.521 |
LIG_SUMO_SIM_par_1 | 130 | 136 | PF11976 | 0.413 |
LIG_SUMO_SIM_par_1 | 35 | 40 | PF11976 | 0.226 |
LIG_WRC_WIRS_1 | 38 | 43 | PF05994 | 0.249 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.483 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.770 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.341 |
MOD_Cter_Amidation | 229 | 232 | PF01082 | 0.413 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.471 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.657 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.560 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.468 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.442 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.386 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.298 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.303 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.468 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.716 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.371 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.556 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.607 |
MOD_N-GLC_1 | 12 | 17 | PF02516 | 0.412 |
MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.652 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.661 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.277 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.451 |
MOD_NEK2_2 | 133 | 138 | PF00069 | 0.501 |
MOD_NEK2_2 | 87 | 92 | PF00069 | 0.341 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.407 |
MOD_Plk_1 | 12 | 18 | PF00069 | 0.489 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.344 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.219 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.464 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.299 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.349 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.440 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.403 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.540 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.390 |
TRG_Pf-PMV_PEXEL_1 | 58 | 62 | PF00026 | 0.488 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7E3 | Leptomonas seymouri | 47% | 100% |
A0A0S4JMP4 | Bodo saltans | 28% | 96% |
A0A3S7WXN1 | Leishmania donovani | 77% | 100% |
A4I0A4 | Leishmania infantum | 77% | 100% |
E9AW69 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
Q4QBA9 | Leishmania major | 75% | 100% |